S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
66,000% upside on tiny biotech? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
66,000% upside on tiny biotech? (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
66,000% upside on tiny biotech? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
66,000% upside on tiny biotech? (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
66,000% upside on tiny biotech? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
66,000% upside on tiny biotech? (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Alibaba Unveils Its Spin-Off Plans
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
66,000% upside on tiny biotech? (Ad)
Can the Dow's 2023 Runaway Winners Keep Running?
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
66,000% upside on tiny biotech? (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
NASDAQ:ADUS

Addus HomeCare (ADUS) Stock Forecast, Price & News

$90.15
+1.78 (+2.01%)
(As of 05/31/2023 ET)
Compare
Today's Range
$88.13
$90.69
50-Day Range
$80.75
$114.02
52-Week Range
$73.65
$114.99
Volume
177,036 shs
Average Volume
126,524 shs
Market Capitalization
$1.46 billion
P/E Ratio
29.08
Dividend Yield
N/A
Price Target
$112.75

Addus HomeCare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
25.1% Upside
$112.75 Price Target
Short Interest
Healthy
1.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.50
Upright™ Environmental Score
News Sentiment
0.91mentions of Addus HomeCare in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$78,810 Sold Last Quarter
Proj. Earnings Growth
12.50%
From $3.60 to $4.05 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.07 out of 5 stars

Medical Sector

24th out of 1,006 stocks

Home Health Care Services Industry

2nd out of 7 stocks


ADUS stock logo

About Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Stock News Headlines

Major Financial Crisis Could Hit America
Something strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs?
Oppenheimer Keeps Their Buy Rating on Addus Homecare (ADUS)
Addus HomeCare (NASDAQ: ADUS)
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Addus HomeCare (NASDAQ:ADUS) Downgraded by StockNews.com
Addus HomeCare (NASDAQ:ADUS) PT Lowered to $109.00
Addus HomeCare (NASDAQ:ADUS) Price Target Cut to $118.00
See More Headlines
Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Company Calendar

Last Earnings
10/31/2021
Today
6/01/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADUS
Employees
33,182
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$112.75
High Stock Price Forecast
$123.00
Low Stock Price Forecast
$101.00
Forecasted Upside/Downside
+25.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$46.03 million
Pretax Margin
6.63%

Debt

Sales & Book Value

Annual Sales
$951.12 million
Cash Flow
$4.23 per share
Book Value
$40.04 per share

Miscellaneous

Free Float
15,491,000
Market Cap
$1.46 billion
Optionable
Optionable
Beta
0.89

Key Executives

  • R. Dirk AllisonR. Dirk Allison
    Chairman & Chief Executive Officer
  • W. Bradley BickhamW. Bradley Bickham
    President & Chief Operating Officer
  • Brian W. PoffBrian W. Poff
    CFO, Secretary, Treasurer & Executive VP
  • Nick Duthie
    Vice President-Information Technology
  • Michael WattenbargerMichael Wattenbarger
    Chief Information Officer & Executive VP













ADUS Stock - Frequently Asked Questions

Should I buy or sell Addus HomeCare stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ADUS shares.
View ADUS analyst ratings
or view top-rated stocks.

What is Addus HomeCare's stock price forecast for 2023?

4 equities research analysts have issued 12 month price objectives for Addus HomeCare's stock. Their ADUS share price forecasts range from $101.00 to $123.00. On average, they anticipate the company's stock price to reach $112.75 in the next year. This suggests a possible upside of 25.1% from the stock's current price.
View analysts price targets for ADUS
or view top-rated stocks among Wall Street analysts.

How have ADUS shares performed in 2023?

Addus HomeCare's stock was trading at $99.49 at the start of the year. Since then, ADUS stock has decreased by 9.4% and is now trading at $90.15.
View the best growth stocks for 2023 here
.

Are investors shorting Addus HomeCare?

Addus HomeCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 284,900 shares, a drop of 46.6% from the April 30th total of 533,100 shares. Based on an average daily trading volume, of 154,700 shares, the days-to-cover ratio is currently 1.8 days. Currently, 1.8% of the shares of the stock are sold short.
View Addus HomeCare's Short Interest
.

When is Addus HomeCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our ADUS earnings forecast
.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $216.66 million for the quarter, compared to the consensus estimate of $227.11 million. Addus HomeCare had a net margin of 5.15% and a trailing twelve-month return on equity of 8.87%. The business's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period last year, the firm posted $0.69 EPS.

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.57%), Silvercrest Asset Management Group LLC (4.53%), Wellington Management Group LLP (4.18%), Dimensional Fund Advisors LP (3.84%), Principal Financial Group Inc. (3.84%) and State Street Corp (3.41%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham.
View institutional ownership trends
.

How do I buy shares of Addus HomeCare?

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $90.15.

How much money does Addus HomeCare make?

Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.46 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $3.10 on an earnings per share basis.

How many employees does Addus HomeCare have?

The company employs 33,182 workers across the globe.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707.

This page (NASDAQ:ADUS) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -